Nuo Therapeutics, Inc. (AURX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Nuo Therapeutics, Inc. (AURX).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $1.65

Daily Change: +$0.15 / 9.09%

Range: $1.45 - $1.67

Market Cap: $78,182,888

Volume: 12,200

Performance Metrics

1 Week: 9.09%

1 Month: 15.38%

3 Months: 1.69%

6 Months: 114.3%

1 Year: 87.50%

YTD: 9.04%

Company Details

Employees: 9

Sector: Health technology

Industry: Medical specialties

Country: United States

Details

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.

Selected stocks

Kingspan Group plc. (KGSPF)

Permanent TSB Group Holdings plc (ILPMY)

SCHAEFFLER AG (SFFLY)